| 发明名称 |
Method of diagnosing cancer based on MED15 and/or MED12 |
| 摘要 |
<p>The present invention relates to methods of diagnosing cancer, determining the prognosis of a patient diagnosed with cancer and identifying a compound for treatment of cancer, using MED15 and/or MED12 as markers. In particular, the cancer is prostate cancer, castration-resistant prostate cancer (CRPC), distant metastatic CRPC or local recurrent CRPC. Furthermore, the invention relates to compounds for the treatment of cancer and use of MED15 and/or MED12 for diagnosis of cancer or prognosis of a patient suffering from cancer.</p> |
| 申请公布号 |
EP2837694(A1) |
申请公布日期 |
2015.02.18 |
| 申请号 |
EP20130180632 |
申请日期 |
2013.08.16 |
| 申请人 |
RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN |
发明人 |
PERNER, SVEN;SHAIKHIBRAHIM, ZAKI;MENON, ROOPIKA;BRAUN, MARTIN |
| 分类号 |
C12Q1/68;C12N15/113;G01N33/574 |
主分类号 |
C12Q1/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
